Recent Advances in Manufacturing Innovative Stents.
bioresorbable stent stent manufacturing
drug-eluting stent
stent
stent coating
titanium oxynitride coating
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
13 Apr 2020
13 Apr 2020
Historique:
received:
22
02
2020
revised:
09
04
2020
accepted:
10
04
2020
entrez:
17
4
2020
pubmed:
17
4
2020
medline:
17
4
2020
Statut:
epublish
Résumé
Cardiovascular diseases are the most distributed cause of death worldwide. Stenting of arteries as a percutaneous transluminal angioplasty procedure became a promising minimally invasive therapy based on re-opening narrowed arteries by stent insertion. In order to improve and optimize this method, many research groups are focusing on designing new or improving existent stents. Since the beginning of the stent development in 1986, starting with bare-metal stents (BMS), these devices have been continuously enhanced by applying new materials, developing stent coatings based on inorganic and organic compounds including drugs, nanoparticles or biological components such as genes and cells, as well as adapting stent designs with different fabrication technologies. Drug eluting stents (DES) have been developed to overcome the main shortcomings of BMS or coated stents. Coatings are mainly applied to control biocompatibility, degradation rate, protein adsorption, and allow adequate endothelialization in order to ensure better clinical outcome of BMS, reducing restenosis and thrombosis. As coating materials (i) organic polymers: polyurethanes, poly(ε-caprolactone), styrene-b-isobutylene-b-styrene, polyhydroxybutyrates, poly(lactide-co-glycolide), and phosphoryl choline; (ii) biological components: vascular endothelial growth factor (VEGF) and anti-CD34 antibody and (iii) inorganic coatings: noble metals, wide class of oxides, nitrides, silicide and carbide, hydroxyapatite, diamond-like carbon, and others are used. DES were developed to reduce the tissue hyperplasia and in-stent restenosis utilizing antiproliferative substances like paclitaxel, limus (siro-, zotaro-, evero-, bio-, amphi-, tacro-limus), ABT-578, tyrphostin AGL-2043, genes, etc. The innovative solutions aim at overcoming the main limitations of the stent technology, such as in-stent restenosis and stent thrombosis, while maintaining the prime requirements on biocompatibility, biodegradability, and mechanical behavior. This paper provides an overview of the existing stent types, their functionality, materials, and manufacturing conditions demonstrating the still huge potential for the development of promising stent solutions.
Identifiants
pubmed: 32294908
pii: pharmaceutics12040349
doi: 10.3390/pharmaceutics12040349
pmc: PMC7238261
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : EraNetRus Plus
ID : B6-ASM/855213-068
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Bioconjug Chem. 2015 Jul 15;26(7):1277-88
pubmed: 26041505
Eur Heart J. 2005 Aug;26(15):1475-81
pubmed: 15975990
EuroIntervention. 2006 May;2(1):113-5
pubmed: 19755245
J Pharm Sci. 1996 Jan;85(1):29-31
pubmed: 8926579
J Am Coll Cardiol. 2017 Jun 27;69(25):3055-3066
pubmed: 28412389
EuroIntervention. 2008 Aug;4(2):234-41
pubmed: 19110789
J Biomed Mater Res A. 2010 Apr;93(1):1-11
pubmed: 19437432
Cell Biochem Biophys. 2013 Jul;66(3):855-66
pubmed: 23456453
N Engl J Med. 2004 Jan 15;350(3):221-31
pubmed: 14724301
J Funct Biomater. 2012 Apr 17;3(2):283-97
pubmed: 24955532
Heart. 2001 Nov;86(5):563-9
pubmed: 11602554
EuroIntervention. 2009 Dec 15;5 Suppl F:F94-7
pubmed: 22100686
JACC Cardiovasc Interv. 2014 Mar;7(3):315-24
pubmed: 24529931
Mater Sci Eng C Mater Biol Appl. 2017 Nov 1;80:1-6
pubmed: 28866142
Nanomedicine (Lond). 2012 Dec;7(12):1907-16
pubmed: 23249334
Biomaterials. 2017 Nov;145:92-105
pubmed: 28858721
Acta Biomater. 2017 Oct 15;62:418-433
pubmed: 28823717
J Interv Cardiol. 2018 Jun;31(3):330-337
pubmed: 29464786
Eur Heart J. 2009 Oct;30(20):2441-9
pubmed: 19720642
Int J Pharm. 2013 Jan 30;441(1-2):665-79
pubmed: 23117022
J Appl Biomater Funct Mater. 2020 Jan-Dec;18:2280800019887906
pubmed: 31996069
Catheter Cardiovasc Interv. 2005 Jan;64(1):85-90
pubmed: 15619311
Theranostics. 2014 Jan 08;4(2):175-200
pubmed: 24465275
Catheter Cardiovasc Interv. 2006 Oct;68(4):607-17; discussion 618-9
pubmed: 16969879
JACC Cardiovasc Interv. 2009 Apr;2(4):312-20
pubmed: 19463443
Biomed Tech (Berl). 2013 Oct;58(5):439-52
pubmed: 23979121
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2563-8
pubmed: 17885211
ACS Biomater Sci Eng. 2016 Dec 12;2(12):2355-2364
pubmed: 33465884
Ann Med. 2009;41(8):599-607
pubmed: 19701826
Am Heart J. 2003 Apr;145(4):e17
pubmed: 12679775
Minerva Cardioangiol. 2009 Oct;57(5):537-65
pubmed: 19838147
Int J Cardiovasc Imaging. 2012 Dec;28(8):1859-66
pubmed: 22362097
J Long Term Eff Med Implants. 2000;10(1-2):79-95
pubmed: 10947632
Lancet. 2008 Sep 27;372(9644):1163-73
pubmed: 18765162
Tissue Eng. 2004 May-Jun;10(5-6):699-710
pubmed: 15265287
Biomed Tech (Berl). 2009 Apr;54(2):98-106
pubmed: 19335124
AJR Am J Roentgenol. 1998 Feb;170(2):403-8
pubmed: 9456954
J Biomech Eng. 2012 Dec;134(12):121005
pubmed: 23363207
Cardiovasc Intervent Radiol. 1998 Nov-Dec;21(6):497-500
pubmed: 9853168
Biomaterials. 2006 Oct;27(28):4955-62
pubmed: 16765434
J Control Release. 2005 Jan 20;102(1):123-33
pubmed: 15653139
Biomaterials. 2010 Feb;31(4):602-7
pubmed: 19828193
Biomed Eng Online. 2016 Feb 20;15:21
pubmed: 26897123
Biomaterials. 2009 Feb;30(4):484-98
pubmed: 19000636
Appl Biochem Biotechnol. 2012 Nov;168(6):1434-47
pubmed: 22976852
Adv Sci (Weinh). 2018 Apr 23;5(6):1701043
pubmed: 29938181
Circulation. 2004 Apr 27;109(16):1948-54
pubmed: 15078794
J Invasive Cardiol. 2006 Feb;18(2):70-4
pubmed: 16446520
Circ J. 2018 Jan 25;82(2):477-485
pubmed: 28717068
J Mech Behav Biomed Mater. 2011 Apr;4(3):352-65
pubmed: 21316623
Mini Rev Med Chem. 2014;14(6):505-36
pubmed: 24873819
Heart. 2000 Mar;83(3):338-45
pubmed: 10677417
Mol Pharm. 2015 Jul 6;12(7):2305-17
pubmed: 25936529
Pharm Res. 2013 Jul;30(7):1735-48
pubmed: 23568519
J Control Release. 2012 Jul 20;161(2):703-12
pubmed: 22366546
Biomaterials. 2007 Mar;28(9):1689-710
pubmed: 17188349
Med Devices (Auckl). 2010;3:57-66
pubmed: 22915922
J Biomed Mater Res B Appl Biomater. 2018 Jan;106(1):88-95
pubmed: 27875036
Small. 2016 Nov;12(43):6012-6023
pubmed: 27623489
Circulation. 2004 Jul 6;110(1):36-45
pubmed: 15210598
Adv Drug Deliv Rev. 2012 Nov;64(14):1590-602
pubmed: 22465783
Circulation. 2007 May 8;115(18):2435-41
pubmed: 17438147
Endoscopy. 1998 May;30(4):345-50
pubmed: 9689506
Int J Mol Sci. 2013 Dec 16;14(12):24492-500
pubmed: 24351829
Hum Gene Ther. 2006 Jul;17(7):741-50
pubmed: 16839273
Sci Rep. 2017 Apr 26;7(1):1173
pubmed: 28446750
J Biomed Mater Res B Appl Biomater. 2011 Feb;96(2):333-41
pubmed: 21210514
J Am Coll Cardiol. 2011 Jan 25;57(4):390-8
pubmed: 21251578
Materials (Basel). 2018 Jun 09;11(6):
pubmed: 29890754
Ann Biomed Eng. 2016 Feb;44(2):341-56
pubmed: 26271520
Int J Cardiol. 2010 Sep 24;144(1):42-6
pubmed: 19403187
Biomaterials. 2013 Oct;34(31):7584-91
pubmed: 23863453
J Interv Cardiol. 2008 Feb;21(1):15-20
pubmed: 18086136
Eur Heart J. 2012 Jan;33(1):16-25b
pubmed: 22041548
J Mater Sci Mater Med. 2017 Sep 27;28(11):174
pubmed: 28956207
Med Sci Monit. 2002 Feb;8(2):PI16-20
pubmed: 11859292
Biomaterials. 2003 Jun;24(13):2177-87
pubmed: 12699653
Eur Heart J. 2007 Oct;28(19):2319
pubmed: 17485484
Heart. 2003 Jun;89(6):651-6
pubmed: 12748224
Adv Drug Deliv Rev. 2006 Jun 3;58(3):387-401
pubmed: 16546289
Acta Biomater. 2010 May;6(5):1714-25
pubmed: 19788945
Biomaterials. 2006 Apr;27(10):2193-200
pubmed: 16310850
Int J Pharm. 2013 Mar 10;445(1-2):20-8
pubmed: 23380625
Curr Vasc Pharmacol. 2012 Jan;10(1):4-18
pubmed: 22112350
J Vasc Interv Radiol. 2017 Nov;28(11):1584-1591
pubmed: 28893465
Cathet Cardiovasc Diagn. 1998 Oct;45(2):202-7
pubmed: 9786403
N Engl J Med. 2013 Jan 17;368(3):254-65
pubmed: 23323902
Circulation. 2000 Jul 25;102(4):399-404
pubmed: 10908211
Acta Biomater. 2017 Aug;58:539-549
pubmed: 28532901
Chonnam Med J. 2017 Jan;53(1):14-27
pubmed: 28184335
Drug Deliv Transl Res. 2018 Aug;8(4):903-917
pubmed: 28799125
Radiology. 1995 Jun;195(3):821-7
pubmed: 7538682
Cardiovasc Intervent Radiol. 2006 Jan-Feb;29(1):11-6
pubmed: 16195840
Acta Biomater. 2017 Jan 15;48:541-550
pubmed: 27780765
Mater Sci Eng C Mater Biol Appl. 2019 Jun;99:405-416
pubmed: 30889715
J Am Coll Cardiol. 2010 Aug 31;56(10 Suppl):S43-78
pubmed: 20797503
Adv Healthc Mater. 2016 May;5(10):1121-40
pubmed: 27094868
Acta Biomater. 2010 Feb;6(2):626-40
pubmed: 19545650
N Engl J Med. 1994 Aug 25;331(8):496-501
pubmed: 8041414
J Biomed Mater Res B Appl Biomater. 2018 Jan;106(1):245-258
pubmed: 28130871
Circ Res. 2001 Jan 19;88(1):77-83
pubmed: 11139477
Am Heart J. 2014 Apr;167(4):445-51
pubmed: 24655691
Neurosurg Focus. 2017 Apr;42(4):E11
pubmed: 28366059
World J Gastroenterol. 2016 Sep 14;22(34):7841-50
pubmed: 27678367
J Interv Cardiol. 2003 Aug;16(4):325-33
pubmed: 14562673
J Biomed Mater Res A. 2007 Dec 15;83(4):1192-1199
pubmed: 17600326
J Med Device. 2017 Jun;11(2):0210101-210109
pubmed: 28690712
Circulation. 2003 Feb 11;107(5):777-84
pubmed: 12578884
Angiology. 2007 Apr-May;58(2):203-10
pubmed: 17495270
Arch Cardiovasc Dis. 2015 Jun-Jul;108(6-7):385-97
pubmed: 26113479
Curr Pharm Des. 2018;24(4):402-413
pubmed: 29283053
J Interv Cardiol. 2003 Dec;16(6):499-505
pubmed: 14632947
Am J Gastroenterol. 1995 Dec;90(12):2143-6
pubmed: 8540504
Phys Chem Chem Phys. 2018 Jan 31;20(5):3602-3607
pubmed: 29340380
Oxid Med Cell Longev. 2016;2016:9782346
pubmed: 26798429
N Engl J Med. 2017 Jun 15;376(24):2319-2328
pubmed: 28402237
J Biomed Mater Res. 1998 May;40(2):324-35
pubmed: 9549628
Physiol Rev. 1993 Jan;73(1):79-118
pubmed: 8419966
Mol Pharm. 2013 Apr 1;10(4):1279-98
pubmed: 23394068
Biomed Res Int. 2014;2014:428619
pubmed: 24883312
J Biomater Appl. 2011 May;25(8):851-75
pubmed: 20237179
Gene Ther. 2012 Mar;19(3):321-8
pubmed: 21716298
Int J Pharm. 2018 Jun 15;544(2):392-401
pubmed: 29229513
Thromb Haemost. 2013 Apr;109(4):744-54
pubmed: 23364775
Int J Cardiol. 2004 Jun;95(2-3):329-31
pubmed: 15193840
J Am Coll Cardiol. 2005 Jul 19;46(2):231-6
pubmed: 16022947
ACS Appl Mater Interfaces. 2009 May;1(5):1053-62
pubmed: 20355891
Cell Commun Adhes. 2003 Jan-Feb;10(1):17-26
pubmed: 12881037
J Biomed Nanotechnol. 2014 Jul;10(7):1194-204
pubmed: 24804540
ACS Biomater Sci Eng. 2017 Apr 10;3(4):518-529
pubmed: 33429619
Kardiologiia. 2004;44(3):77
pubmed: 15489834
J Biomed Mater Res A. 2015 Jan;103(1):341-9
pubmed: 24665048
J Mater Chem B. 2017 Mar 7;5(9):1787-1802
pubmed: 32263920
Circulation. 1996 Sep 15;94(6):1247-54
pubmed: 8822976
Med Eng Phys. 2011 Mar;33(2):148-63
pubmed: 21075668
Circulation. 2004 Feb 3;109(4):487-93
pubmed: 14744971
J Biomed Mater Res A. 2016 Feb;104(2):347-56
pubmed: 26402437
Nat Clin Pract Cardiovasc Med. 2005 Dec;2(12):647-58
pubmed: 16306921
Cardiovasc Res. 2018 Jul 1;114(8):1063-1072
pubmed: 29718125
Adv Drug Deliv Rev. 2006 Jun 3;58(3):377-86
pubmed: 16650911
J Interv Cardiol. 2006 Dec;19(6):500-6
pubmed: 17107364
Anal Bioanal Chem. 2013 Jan;405(1):321-9
pubmed: 23052887
Circ Cardiovasc Interv. 2009 Jun;2(3):255-60
pubmed: 20031723
Rev Bras Cir Cardiovasc. 2015 Mar-Apr;30(2):159-63
pubmed: 26107446
Materials (Basel). 2017 Oct 18;10(10):
pubmed: 29057837
Circulation. 2001 May 8;103(18):2289-95
pubmed: 11342479
Mater Sci Eng C Mater Biol Appl. 2018 Mar 1;84:67-79
pubmed: 29519445
Mol Ther. 2008 Oct;16(10):1674-80
pubmed: 18714308
Adv Mater. 2013 May 14;25(18):2577-82
pubmed: 23495090
Int J Artif Organs. 2002 Dec;25(12):1166-73
pubmed: 12518961
Circulation. 2001 Jul 24;104(4):473-9
pubmed: 11468212
J Interv Cardiol. 2018 Oct;31(5):617-623
pubmed: 29808511
Acta Biomater. 2009 May;5(4):945-58
pubmed: 19111513